JADE101 Phase 1 healthy volunteer interim data expected in the second quarter of 2026; Phase 2 clinical trial in patients with IgA nephropathy expected to begin mid-2026 with preliminary data anticipated in 2027 JADE201, a half-life extended afucosylated anti-BAFF receptor antibody, expected to advance into first-in-human clinical trial in rheumatoid arthritis patients in the second […]
Category Archives: Pr Newswire
Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression remains on track for Q2 2026 following successful End‑of‑Phase 2 meeting with the U.S. Food and Drug Administration On-track for VLS-01 Phase 2 Elumina trial topline data readout anticipated in H2 2026 Exploratory Phase 2a trial of EMP-01 in Social Anxiety Disorder met its primary […]
CHICAGO, March 06, 2026 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial results for the fourth quarter and fiscal year ended on December 31, 2025, before the market opens on Thursday, March 12, 2026. A […]
ACTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid near-patient tests to improve patient outcomes in critical care settings, today provided a corporate update highlighting recent progress and its planned strategic trajectory through 2026. Operational and Clinical ProgressBluejay continues to advance […]
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 06, 2026 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:HCM, HKEX:13) today announces that Professor Mok Shu Kam, Tony has informed the Company that he would not seek re-election after retiring from the Board at the forthcoming annual general meeting of the Company […]
BEIJING, March 6, 2026 /PRNewswire/ — This is a report from China SCIO: China has set an economic growth target of 4.5% to 5% for this year, while pledging to strive for better results as authorities aim to balance structural reforms, risk prevention, and long-term development goals. The goals are outlined in this year’s government work […]
SHENZHEN, China, March 6, 2026 /PRNewswire/ — Technology lifestyle brand Aulumu has been honored with two 2026 iF Design Award recognitions, one of the most prestigious global awards for design excellence. The awards recognize the Aulumu Geometric Case for AirPods Pro and the Aulumu Mag Buckle Ultra-Thin Strap, underscoring the brand’s commitment to combining bold industrial […]
CAMBRIDGE, Mass., March 5, 2026 /PRNewswire/ — Insilico Medicine (Insilico Medicine, HKEX: 03696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced that ISM4808, an AI-driven PHD inhibitor for chronic kidney disease (CKD)-related anemia previously out-licensed to TaiGen Biotechnology (TaiGen*-KY, 4157), has achieved its first milestone. Recently, TaiGen has successfully completed the enrollment […]
DUBAI, UAE, March 6, 2026 /PRNewswire/ — As digital asset markets face renewed volatility and investor sentiment turns cautious, Bybit and Tether, the largest company in the digital asset industry today, announced an expanded collaboration centered on tokenized gold, launching the joint “Golden Season” initiative with more than $1 million in gold-backed rewards. The program builds on […]
VICTORIA, Seychelles, March 6, 2026 /PRNewswire/ — MEXC Foundation and UNCB (University Network for Cryptocurrency & Blockchain) today launched MEXCampus at the Roundhouse, University of New South Wales (UNSW) Campus — formally introducing MEXC as UNCB’s official partner and kicking off a structured trader development program for university students across Australia. MEXCampus Launches at UNSW, Expanding […]
